BTCC / BTCC Square / Global Cryptocurrency /
Wall Street Weighs In on UnitedHealth Stock Amid Selloff

Wall Street Weighs In on UnitedHealth Stock Amid Selloff

Published:
2025-11-09 14:21:02
8
1
BTCCSquare news:

UnitedHealth Group's stock has tumbled 36% year-to-date despite a strong Q3 earnings beat, with Medicare Advantage cost concerns and a DOJ probe weighing on shares. Bernstein analyst Lance Wilkes sees opportunity in the dip, raising his price target to $440 and maintaining a Buy rating.

Margin recovery in MA and Medicaid businesses could fuel an earnings rebound, Wilkes argues, citing upcoming rate cuts and reduced competition. The stock's current valuation appears attractive given projected EPS growth through 2027.

|Square

Get the BTCC app to start your crypto journey

Get started today Scan to join our 100M+ users

All articles reposted on this platform are sourced from public networks and are intended solely for the purpose of disseminating industry information. They do not represent any official stance of BTCC. All intellectual property rights belong to their original authors. If you believe any content infringes upon your rights or is suspected of copyright violation, please contact us at [email protected]. We will address the matter promptly and in accordance with applicable laws.BTCC makes no explicit or implied warranties regarding the accuracy, timeliness, or completeness of the republished information and assumes no direct or indirect liability for any consequences arising from reliance on such content. All materials are provided for industry research reference only and shall not be construed as investment, legal, or business advice. BTCC bears no legal responsibility for any actions taken based on the content provided herein.